icosapent ethyl
Cardiovascular system (C10)US regulatory status: approved. Mechanism: Unknown.
- Mechanism
- Unknown
pharma · Hypertriglyceridemia
Mochida Pharmaceutical
Mochida Pharmaceutical Company,
Mochida Pharmaceutical drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
USA HQ
42 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- USA
- Employees
- 42
- Programs
- 3
- Drugs
- 2
- Patents
- 0
Mochida Pharmaceutical pipeline
Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Mochida Pharmaceutical drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Mochida Pharmaceutical in public FDA and regional records.